{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:24:55Z","timestamp":1780687495524,"version":"3.54.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"8","funder":[{"name":"FWF","award":["P26421"],"award-info":[{"award-number":["P26421"]}]},{"name":"FWF","award":["PMUFFF E-10\/11\/058-HAR"],"award-info":[{"award-number":["PMUFFF E-10\/11\/058-HAR"]}]},{"name":"Immunity in Cancer and Allergy","award":["W1213"],"award-info":[{"award-number":["W1213"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The proliferation of chronic lymphocytic leukemia (CLL) cells requires communication with the lymphoid organ microenvironment. Integrin-linked kinase (ILK) is a multifunctional intracellular adaptor protein that transmits extracellular signals to regulate malignant cell motility, metastasis, and cell-cycle progression, but is poorly characterized in hematologic malignancies. In this study, we investigated the role of ILK in the context of CLL and observed high ILK expression in patient samples, particularly in tumor cells harboring prognostic high-risk markers such as unmutated IGHV genes, high Zap70, or CD38 expression, or a signature of recent proliferation. We also found increased numbers of Ki67 (MKI67)-positive cells in regions of enhanced ILK expression in lymph nodes from CLL patients. Using coculture conditions mimicking the proliferative lymph node microenvironment, we detected a parallel induction of ILK and cyclin D1 (CCND1) expression in CLL cells that was dependent on the activation of NF-\u03baB signaling by soluble TNF\u03b1. The newly synthesized ILK protein colocalized to centrosomal structures and was required for correct centrosome clustering and mitotic spindle organization. Furthermore, we established a mouse model of CLL in which B-cell\u2013specific genetic ablation of ILK resulted in decelerated leukemia development due to reduced organ infiltration and proliferation of CLL cells. Collectively, our findings describe a TNF\u03b1\u2013NF-\u03baB\u2013mediated mechanism by which ILK expression is induced in the lymph node microenvironment and propose that ILK promotes leukemogenesis by enabling CLL cells to cope with centrosomal defects acquired during malignant transformation. Cancer Res; 76(8); 2186\u201396. \u00a92016 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-15-3379","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T23:08:55Z","timestamp":1454454535000},"page":"2186-2196","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["ILK Induction in Lymphoid Organs by a TNF\u03b1\u2013NF-\u03baB\u2013Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia"],"prefix":"10.1158","volume":"76","author":[{"given":"Peter W.","family":"Krenn","sequence":"first","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian W.","family":"Hofbauer","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Pucher","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Hutterer","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Hinterseer","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Denk","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Asslaber","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Ganghammer","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Sternberg","sequence":"additional","affiliation":[{"name":"3Department of Molecular Biology, Division of Molecular Tumor Biology, University of Salzburg, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Neureiter","sequence":"additional","affiliation":[{"name":"4Institute of Pathology, Paracelsus Medical University, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Aberger","sequence":"additional","affiliation":[{"name":"3Department of Molecular Biology, Division of Molecular Tumor Biology, University of Salzburg, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Wickstr\u00f6m","sequence":"additional","affiliation":[{"name":"5Paul Gerson Unna Group \u2018Skin Homeostasis and Ageing,\u2019 Max Planck Institute for Biology of Ageing, Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Egle","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Greil","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja N.","family":"Hartmann","sequence":"additional","affiliation":[{"name":"1Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University, Salzburg, Austria."},{"name":"2Salzburg Cancer Research Institute, Salzburg, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"2022061706024370000_bib1","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3324\/haematol.11448","article-title":"Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro.","volume":"92","author":"Backman","year":"2007","journal-title":"Haematologica"},{"key":"2022061706024370000_bib2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y","article-title":"Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.","volume":"32","author":"Ghia","year":"2002","journal-title":"Eur J Immunol"},{"key":"2022061706024370000_bib3","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","article-title":"Distinctive features of \"nurselike\" cells that differentiate in the context of chronic lymphocytic leukemia.","volume":"99","author":"Tsukada","year":"2002","journal-title":"Blood"},{"key":"2022061706024370000_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1200\/JCO.2008.19.1114","article-title":"Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia.","volume":"27","author":"Hewamana","year":"2009","journal-title":"J Clin Oncol"},{"key":"2022061706024370000_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"2022061706024370000_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2119\/molmed.2012.00303","article-title":"Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.","volume":"20","author":"Mittal","year":"2014","journal-title":"Mol Med"},{"key":"2022061706024370000_bib7","doi-asserted-by":"crossref","first-page":"e23758","DOI":"10.1371\/journal.pone.0023758","article-title":"Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.","volume":"6","author":"Brachtl","year":"2011","journal-title":"PLoS One"},{"key":"2022061706024370000_bib8","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1158\/0008-5472.CAN-08-4136","article-title":"Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.","volume":"69","author":"Hartmann","year":"2009","journal-title":"Cancer Res"},{"key":"2022061706024370000_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/379091a0","article-title":"Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase.","volume":"379","author":"Hannigan","year":"1996","journal-title":"Nature"},{"key":"2022061706024370000_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrm1789","article-title":"ILK, PINCH and parvin: the tIPP of integrin signalling.","volume":"7","author":"Legate","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022061706024370000_bib11","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1242\/jcs.017996","article-title":"Integrin-linked kinase\u2013essential roles in physiology and cancer biology.","volume":"121","author":"McDonald","year":"2008","journal-title":"J Cell Sci"},{"key":"2022061706024370000_bib12","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1038\/sj.onc.1203928","article-title":"The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9).","volume":"19","author":"Troussard","year":"2000","journal-title":"Oncogene"},{"key":"2022061706024370000_bib13","doi-asserted-by":"crossref","first-page":"13937","DOI":"10.1074\/jbc.272.21.13937","article-title":"Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression.","volume":"272","author":"Radeva","year":"1997","journal-title":"J Biol Chem"},{"key":"2022061706024370000_bib14","doi-asserted-by":"crossref","first-page":"32649","DOI":"10.1074\/jbc.M000643200","article-title":"The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.","volume":"275","author":"D'Amico","year":"2000","journal-title":"J Biol Chem"},{"key":"2022061706024370000_bib15","doi-asserted-by":"crossref","first-page":"11528","DOI":"10.1074\/jbc.M208337200","article-title":"Ca2+-dependent localization of integrin-linked kinase to cell junctions in differentiating keratinocytes.","volume":"278","author":"Vespa","year":"2003","journal-title":"J Biol Chem"},{"key":"2022061706024370000_bib16","doi-asserted-by":"crossref","first-page":"e53702","DOI":"10.1371\/journal.pone.0053702","article-title":"Integrin-linked kinase regulates interphase and mitotic microtubule dynamics.","volume":"8","author":"Lim","year":"2013","journal-title":"PLoS One"},{"key":"2022061706024370000_bib17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.devcel.2010.09.007","article-title":"Integrin-linked kinase controls microtubule dynamics required for plasma membrane targeting of caveolae.","volume":"19","author":"Wickstrom","year":"2010","journal-title":"Dev Cell"},{"key":"2022061706024370000_bib18","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1021\/pr700852r","article-title":"Mapping the integrin-linked kinase interactome using SILAC.","volume":"7","author":"Dobreva","year":"2008","journal-title":"J Proteome Res"},{"key":"2022061706024370000_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/onc.2010.431","article-title":"A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells.","volume":"30","author":"Fielding","year":"2011","journal-title":"Oncogene"},{"key":"2022061706024370000_bib20","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1200\/JCO.2007.11.5212","article-title":"MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.","volume":"26","author":"Gryshchenko","year":"2008","journal-title":"J Clin Oncol"},{"key":"2022061706024370000_bib21","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia.","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"2022061706024370000_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cyto.b.20132","article-title":"Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.","volume":"70","author":"Letestu","year":"2006","journal-title":"Cytometry B Clin Cytom"},{"key":"2022061706024370000_bib23","doi-asserted-by":"crossref","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","article-title":"IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples.","volume":"9","author":"Varghese","year":"2014","journal-title":"PLoS One"},{"key":"2022061706024370000_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/bjh.12151","article-title":"Mimicking the microenvironment in chronic lymphocytic leukaemia - where does the journey go?","volume":"160","author":"Asslaber","year":"2013","journal-title":"Br J Haematol"},{"key":"2022061706024370000_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bjh.13188","article-title":"CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.","volume":"169","author":"Hutterer","year":"2015","journal-title":"Br J Haematol"},{"key":"2022061706024370000_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome.","volume":"489","author":"ENCODE Project Consortium","year":"2012","journal-title":"Nature"},{"key":"2022061706024370000_bib27","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706024370000_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/nar\/25.6.1317","article-title":"B lymphocyte-specific, Cre-mediated mutagenesis in mice.","volume":"25","author":"Rickert","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"2022061706024370000_bib29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1101\/gad.255603","article-title":"Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation.","volume":"17","author":"Sakai","year":"2003","journal-title":"Genes Dev"},{"key":"2022061706024370000_bib30","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2119\/molmed.2011.00360","article-title":"Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born\/divided and older\/quiescent cells.","volume":"17","author":"Calissano","year":"2011","journal-title":"Mol Med"},{"key":"2022061706024370000_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0145-2126(94)90090-6","article-title":"Redox reagents and staurosporine inhibit stimulation of the transcription regulator NF-kappa B following tumour necrosis factor treatment of chronic B-leukaemia cells.","volume":"18","author":"Jabbar","year":"1994","journal-title":"Leuk Res"},{"key":"2022061706024370000_bib32","doi-asserted-by":"crossref","first-page":"27776","DOI":"10.1074\/jbc.M114.574541","article-title":"Integrin-linked kinase modulates lipopolysaccharide- and Helicobacter pylori-induced nuclear factor \u03baB-activated tumor necrosis factor-\u03b1 production via regulation of p65 serine 536 phosphorylation.","volume":"289","author":"Ahmed","year":"2014","journal-title":"J Biol Chem"},{"key":"2022061706024370000_bib33","doi-asserted-by":"crossref","first-page":"21096","DOI":"10.1074\/jbc.272.34.21096","article-title":"Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.","volume":"272","author":"Pierce","year":"1997","journal-title":"J Biol Chem"},{"key":"2022061706024370000_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/A:1024116916932","article-title":"Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties.","volume":"8","author":"Caserta","year":"2003","journal-title":"Apoptosis"},{"key":"2022061706024370000_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2006-12-060947","article-title":"Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells.","volume":"110","author":"Ougolkov","year":"2007","journal-title":"Blood"},{"key":"2022061706024370000_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0092-8674(94)90504-5","article-title":"Pericentrin, a highly conserved centrosome protein involved in microtubule organization.","volume":"76","author":"Doxsey","year":"1994","journal-title":"Cell"},{"key":"2022061706024370000_bib37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0092-8674(91)90390-K","article-title":"Gamma-tubulin is a highly conserved component of the centrosome.","volume":"65","author":"Stearns","year":"1991","journal-title":"Cell"},{"key":"2022061706024370000_bib38","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ijc.22752","article-title":"High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia.","volume":"121","author":"Hensel","year":"2007","journal-title":"Int J Cancer"},{"key":"2022061706024370000_bib39","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/leu.2011.111","article-title":"Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL.","volume":"25","author":"Hofbauer","year":"2011","journal-title":"Leukemia"},{"key":"2022061706024370000_bib40","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(88)91782-5","article-title":"Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.","volume":"1","author":"Cordingley","year":"1988","journal-title":"Lancet"},{"key":"2022061706024370000_bib41","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/leu.2014.105","article-title":"Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia.","volume":"28","author":"Saulep-Easton","year":"2014","journal-title":"Leukemia"},{"key":"2022061706024370000_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10735-013-9540-5","article-title":"Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-kappaB pathway.","volume":"45","author":"Liang","year":"2014","journal-title":"J Mol Histol"},{"key":"2022061706024370000_bib43","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1038\/onc.2010.644","article-title":"Integrin-linked kinase regulates melanoma angiogenesis by activating NF-kappaB\/interleukin-6 signaling pathway.","volume":"30","author":"Wani","year":"2011","journal-title":"Oncogene"},{"key":"2022061706024370000_bib44","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2013-08-523563","article-title":"Tiam1\/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells.","volume":"123","author":"Hofbauer","year":"2014","journal-title":"Blood"},{"key":"2022061706024370000_bib45","doi-asserted-by":"crossref","first-page":"8389","DOI":"10.1038\/srep08389","article-title":"Integrin-linked kinase links dynactin-1\/dynactin-2 with cortical integrin receptors to orient the mitotic spindle relative to the substratum.","volume":"5","author":"Morris","year":"2015","journal-title":"Sci Rep"},{"key":"2022061706024370000_bib46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1556-0864(15)30405-6","article-title":"Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model.","volume":"1","author":"Liu","year":"2006","journal-title":"J Thorac Oncol"},{"key":"2022061706024370000_bib47","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1158\/1535-7163.MCT-05-0078","article-title":"Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer.","volume":"4","author":"Younes","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"2022061706024370000_bib48","doi-asserted-by":"crossref","first-page":"21886","DOI":"10.1074\/jbc.M111.240093","article-title":"Biochemical, proteomic, structural, and thermodynamic characterizations of integrin-linked kinase (ILK): cross-validation of the pseudokinase.","volume":"286","author":"Fukuda","year":"2011","journal-title":"J Biol Chem"},{"key":"2022061706024370000_bib49","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/emboj.2013.90","article-title":"Stabilization of integrin-linked kinase by the Hsp90-CHIP axis impacts cellular force generation, migration and the fibrotic response.","volume":"32","author":"Radovanac","year":"2013","journal-title":"Embo J"},{"key":"2022061706024370000_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1182\/blood-2014-06-583518","article-title":"OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.","volume":"125","author":"Liu","year":"2015","journal-title":"Blood"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/8\/2186\/2869934\/2186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/8\/2186\/2869934\/2186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T12:51:23Z","timestamp":1655470283000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/76\/8\/2186\/619486\/ILK-Induction-in-Lymphoid-Organs-by-a-TNF-NF-B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,4,14]]},"published-print":{"date-parts":[[2016,4,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-15-3379","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22414332.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22414335.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508947","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22414335","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508947.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22414332","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,14]]}}}